Literature DB >> 30368622

Quantum chemical and molecular mechanics studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein.

E Srinivasan1, R Rajasekaran2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that has been associated with mutations in metalloenzyme superoxide dismutase (SOD1) causing protein structural destabilization and aggregation. However, the mechanistic action and the cure for the disease still remain obscure. Herein, we initially studied the conformational preferences of SOD1 protein structures upon substitution of Ala at Gly93 in comparison with that of wild type. Our results corroborated with the previous experimental studies on the aggregation and the destabilizing activity of mutant SOD1 protein G93A. On the therapeutic point of view, we computationally analyzed the influence of resveratrol, a natural polyphenol widely found in red wine on mutant SOD1 relative to wild type, using molecular docking studies. Further, FMO calculations were performed, using GAMESS to study the pair residual interaction on the wild type and mutant complex systems. Consequently, the resveratrol showed greater interaction with mutant than the wild type. Subsequently, we evaluated the conformational preferences of wild type and mutant complex systems, where the protein conformational structures of mutant that were earlier found to lose their conformational stability was regained, upon binding with resveratrol. Similar trend of results were found on the 2-D free energy landscapes of both the wild type and mutant systems. Hence, the combined biophysical and quantum chemical studies in our study supported the results of previous experimental studies, thereby stipulating an action of resveratrol on mutant SOD1 and paving a way for the design of highly potent effective inhibitors against fALS affecting the mankind.

Entities:  

Keywords:  ALS; DMD; Docking; FMO; Resveratrol; SOD1

Mesh:

Substances:

Year:  2018        PMID: 30368622     DOI: 10.1007/s10822-018-0175-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  66 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Rishi Rakhit; Avijit Chakrabartty
Journal:  Biochim Biophys Acta       Date:  2006-05-22

3.  Disease progression of human SOD1 (G93A) transgenic ALS model rats.

Authors:  Arifumi Matsumoto; Yohei Okada; Masanori Nakamichi; Masaya Nakamura; Yoshiaki Toyama; Gen Sobue; Makiko Nagai; Masashi Aoki; Yasuto Itoyama; Hideyuki Okano
Journal:  J Neurosci Res       Date:  2006-01       Impact factor: 4.164

Review 4.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

5.  A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.

Authors:  Seiichi Nagano; Yoko Takahashi; Kazuhiro Yamamoto; Hiroshi Masutani; Noriko Fujiwara; Makoto Urushitani; Toshiyuki Araki
Journal:  Hum Mol Genet       Date:  2015-03-11       Impact factor: 6.150

6.  Ab initio folding of proteins with all-atom discrete molecular dynamics.

Authors:  Feng Ding; Douglas Tsao; Huifen Nie; Nikolay V Dokholyan
Journal:  Structure       Date:  2008-07       Impact factor: 5.006

7.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

Review 8.  Computational approaches to understanding protein aggregation in neurodegeneration.

Authors:  Rachel L Redler; David Shirvanyants; Onur Dagliyan; Feng Ding; Doo Nam Kim; Pradeep Kota; Elizabeth A Proctor; Srinivas Ramachandran; Arpit Tandon; Nikolay V Dokholyan
Journal:  J Mol Cell Biol       Date:  2014-03-11       Impact factor: 6.216

9.  CUPSAT: prediction of protein stability upon point mutations.

Authors:  Vijaya Parthiban; M Michael Gromiha; Dietmar Schomburg
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures.

Authors:  Brittany L T Roberts; Kinaree Patel; Hilda H Brown; David R Borchelt
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more
  3 in total

Review 1.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 2.  Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.

Authors:  Mootaz M Salman; Zaid Al-Obaidi; Philip Kitchen; Andrea Loreto; Roslyn M Bill; Richard Wade-Martins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

3.  Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer's Disease.

Authors:  E Srinivasan; G Chandrasekhar; P Chandrasekar; K Anbarasu; A S Vickram; Iftikhar Aslam Tayubi; R Rajasekaran; Rohini Karunakaran
Journal:  Front Chem       Date:  2021-12-20       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.